| Serial Number | 76481658 |
| Word Mark | DIPENTUM |
| Filing Date | Monday, January 13, 2003 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, November 20, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| In Another Form Statement | The mark was used anywhere in a different form other than that sought to be registered on 05/28/1985. |
| In Another Form Statement | The mark was used in a different form other than that sought to be registered in commerce on 06/15/1981. |
| Description of Mark | The mark consists of the typed word "DIPENTUM" in connection with the logo which consists of two connected magenta hexagons flanked by three balls of decreasing size each above and below the connection. |
| Goods and Services | medicinal compound used in the treatment of various gastrointestinal and rheumatoid disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 23, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Celltech Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rochester, NY 14623 |
| Event Date | Event Description |
| Thursday, November 20, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, November 20, 2003 | ASSIGNED TO EXAMINER |
| Monday, March 24, 2003 | NON-FINAL ACTION MAILED |
| Tuesday, March 18, 2003 | ASSIGNED TO EXAMINER |